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103~ Preserved Basal Raloa=e of Nitric Oxide at 
Spontaneously - Occurring Coronary Spasm Sites 
In PMlents With Variant Angtna 
H, Yamamota, M, Name, H, Orlguehl, 1", l~Jlml, H, Yo~htmurn, KYu~h~ Ko,~et 
Nankln HoPplt~l, Ktt~kyu~ho, Japrln 
~Rckgro~nd: It t~ ~ttll ~nknown whether basal release of nitric oxide (NO) la 
dotlcler~! nt ¢oronary ~pa~m ~ita~. Th~ elm ot tibia study was to Invo~tlgnte 
the ba~¢d ralot~o ol NO nt ~itaa ol ac~lylchellne.l~d~ced coronnq,, spasm 
(ACH.spasm) t~nd ~penlaneo~sty.occL~rrlng coronary apn~m (Spent.spasm). 
whCh I~ mare important pnthophyslologically In patients wllh variant nngle~, 
M~t/~od#: Na-monemethyI.L-nrg nine (L.NMMA ~00 pmol/4 m n), an in. 
hlbitor of NO synth~aa was inlu~od into eoromW arteries in 20 patients 
without ~otvn~w rt,k la¢tam with v~rlanl angina nnd in 10 control p~tiont~, 
GorPn~tq/spaenl wa~ (nd~¢~ort by intr~coronary (nkmlan el ACH (50 .el2 mint 
~n all ~p~aro p~tion(~ The luminal diameter of epicmdinl coronary arteries 
wits i t~es~¢ by q,r~ntltativ~ nngiography, 
R{,~tP3; Baseline coronap/anglogrnms in 0 of 20 opnsm p~tionta showed 
laQitl Bpant.ppoBm (basnllne Coronary dtameler was lass thnn 50% el the di. 
omelet ether ~O~0rbldn dinilmta: ~ponl.BpnBm', 43,6 t 4,5% va ACH.~pasm: 
76.? ~ 5,~%, p - Q,O1), L-NMMA constricted signlt~P, ntly all segmm~tS in 
control p~tt~ntn and both the non-~pa~tlc and ~paatlc ~ites in spasm pn. 
ttanta (% diameter change from baseline: control patients: ~9.3 :t 1,9" and 
~o~.~itsll~ t~ltas: -.8,0 '.~ 2,[i', ? .S  :t: 2,0". spastic silos: 12,5 t 4.6', 
~25,5 :t" B,~*, ACH.spasm nnd Spont.spa,~m, respectively, "P -~ 0,01 vs the 
b~selino), The constrictive mspons~ to L.NMMA at the 8pont-spasm sties 
was grantor than nt tho other sites (p - 0,01). 
Con¢lu,~ton: B~ls~l release el NO exists nt the spasm sites, even when 
coronary spasm I~ occumng spontaneously in patients without coron~lry risk 
t~ctO~,~ wlth variant angina, 
~ Bradyklnln-lnduced Dilation of Coronary 
Resistance Vessels In Patients With 
Hyparcholesterolemla: A Role of Nitric Oxide 
M Kate, N, Shiode, H, Toragawa, T, Yamagata, H, Matsuura, G, Kajiyama, 
F~mt Department of Internal Medicine, Hiroshima University, Hirosh~m,"l, 
Japan 
BaCkgroun¢l: Endotholium-dependont dilations of coronary resistance yes. 
sels mediated by acetylcholine (ACM) are impaired due to depressed trit¢~c 
ox~de tNO) production In hypemhotostorelemic patients, However. it ~S not 
clarified wlleth0r bmdykintn (BK)-induc0d dilation is impeired or not. This 
study was designed to determine whether the ondotheliam-dependont dila. 
tton el coronary resistance vessels mediated by BK is =repaired and whether 
this stgnifiea a depressed NO production in humnn hypercholesterelemla, 
Methods: The coronary vascular responses to ACH and BK were com- 
pared In 12 hyperChelostorotemic and 11 control patients with normal core. 
nary arteries. The responses to BK were repeated after N O-monOmethyI-L-ar- 
ginine infusion in 8 hypercholeatorolemio and 9 control patients. Drug~ were 
inbreed into tr~ taft coronary estium and coronary blood flow (CBF} and 
coronary vascular resistance were calculated by quantitative angiegraphy 
and Doppler flow velocity measurements, 
Resolts: The vasodilator esponse to ACH was reduced in hypercholes- 
terolemic patients (p .. 0.o05). Tl~o response to BK was also reduced m 
hypercholesterelemic patients (p ,: 0.04}, Them wc~s a significant correlation 
between the responses in CBF to ACH and BK (r = 0.56: p - 0.01 ). Howevu,; 
BK-induced dilation was similar between these two groups after NO inhibition. 
Conclusions: Th3so results suggest that endothelium-dependent dilation 
of coronary resistance vessels mediated by ElK is also impaired due to 
depressed NO production in hypercholesterelemia. 
~ Individual and Combined Effects of  Estrogen 
Replacement Therapy and Lovastatln In Women 
With Coronary Disease 
D.M. Herrington, B,L. Werbel, BE. Pusser, T.M. Morgan. Bowman Gray 
School el Medicine Winston.Salem. North Carolina, USA 
6ackground: NCEPII guidelines nuggest estrogen replacement therapy (ERT) 
as an alternative to lipid-lowering drugs in postmenopausal women with core- 
nary adory disease (CAD) and hypedipidemia. But it is unclear if ERT's qpid 
effects equal, exceed, or enhance those of other lipid,lowering drt~gs. 
Methods: Twenty.throe women (moan age 68 yr) with CAD and LDL 
130 mg/dl wore enrolled in a randomized, blinded 3-pedod cross.over teal of 
Promarin 0,625 mg and Provers 2.5 me. Iovastatln 20 me, or bath. Plasma 
liptcc wore massacred at baseline and alter each 6.week treatment period 
Results: Each Individual treatment lowered total cho: ,clare! ~TC) and L[")I=. 
(p ' 0.01). end mlsed HDL (p ~ 0.03). However, ERT + lavastatin lowered 
TC and LDL mot0 than ERT alone (p ..~ 0,001) and raised HBL morn than 
Iovaetaltn alone (p = 0,11). The net affect el comblm~;l therapy on LDL/HDL 
ratio was greater than either treatment alone (p ~ 0.05), Lovastattn also 
blocked the ERT.a¢~octatod increase tn trlgtyca~'ldas (p -~- 0,00t), 
Lipi~ls I~olln~ Lev~t~tin I~RT 0olh 
TC ~49 (5,7) 201 (l~t) ~;~4 (?~) t~ (77) 
LOL I (~,~1 (4,61 1t4 (7.7) 139 (6,~) 1t0 (7,1~) 
HDL 42 (2.0) 47 (2,4] 40 (~,~) 50 l~,3) 
TO 217116,~) t09(2tA) ~37 (20,5) 196{160) 
LOtJHDL 39~ (O tl~) 2:Bl~ (0,2Ol ~94 tO t81 ~',~ (018) 
Conc/o,~ion: Combined ERT plus tcwnst~tin yields morn fsvOf~b!0 plasm~ 
lipid pmlites th~n either treatment alone, 
~ The In•lden©e o1 Caroline Ttroponln I Re!sees 
FOllowing Various Coronary Intervention; A H!ghh/ 
Sensitive Marker to Detect Mi©ro-infarcte 
M,A Knnm. C. Landau, F.W, Menu, E.J. Eic;hhem. Dalla,~ VA Af~d Ctr, UnAv 
el T~xos Soufhtt~stem, Deltas TA', USA 
Cardiac Tropontn I (eTnl), a rogul~teW contractile protein is a unique marker 
of myocardial neeresi~i bocauSo 0t high sensitivity, sp@cificity, and virlually no 
cross reactivity with sketelal tmponln L In Qrder to determine the diagnOstic 
sensitivity of cTnl post.intervention in balloon (BAt, slant (ST), mtablation 
(ROt, and t3CA (DC'), levels were measured to determine the incidence 
ot minor Iniury. as well as to compare its sensitivity with CKMB tettowmg 
the procedure, Pts with acule MI or primary PTCA within 7-t0 days were 
excluded, In 75, Consecutive pts reteTred to the oath lab. c'i'nt [~O.4 noJml), 
CKMB (;-10 lU/1) were measured pre-(eTnl), and 8, 16 (CKMB), and 24 
hrs (cTnl, CKMB) post*coronary tmervention. BA was used as a pnma~ or 
adjunctive device in 74 pts, ST were deployed in 30, Re was used in 13. and 
DC in 6 pie. Five pts worn excluded duo to high pnmary versus secondary 
levels ot cTel. 
Results: Overall. cTnl was elevated in 24 (32%), and CKMB in 8 (10%) 
pts post-PTCA, (p =.  000 1. cTnl vs CKMe). The mean nse of eTnL and 
CKMB was 2,84 ng/ml, and 32.75 IU/I respectively. Fig. t summanzes cTnl 
nee (%) with venous procedures, 
uu 
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3 10" , ~ O 
Conclusions: We conclude that serum eTnl allows a much higher diagnos- 
tic :,'c~racy in detecting minor myocardial injury post-intervention compared 
to CKMB, and that routine measurements of CKME] following PTCA may 
not be useful. Minor cardiac injury is frequent following DCA, common post- 
stenting, and uncommon with mtablation. 
~Does  Bradycardla Promote Coronary Collateral 
Growth in Humans? 
S.R. Patel, J.A. Breall, B,J. Gersh, AP. Levy, Georgetown Univemfly 
Medical Center, Washington. DC, USA 
eackground. The development of mature coronary collaterals in patients 
with obstructive CAD decreases the ischemic burden with a consequent 
impmvemem in symptor.rs systolic function, and a decrease in infest size. 
Chronic bradyeardia has been shown 1o stimulate collateral vessel formation 
in experimental models. We hypothesized that CAD patients with bradycardia 
will demonstrate a better developed collateral circulation compared to a 
control group, 
Methods: Rhythm tracings of cardiac catheterization patients were 
screuned from January to June 1997. All angiograms in patients with heart 
rates ±50 were reviewed. An equivalent number of patients with heart rates 
-65 served as controls. Patients with acute myocardial infarctions, rhythms 
.IACC Fehroarv Igt)1~ ABSI "RA( 'T .~ ~ I',,',tcr IO?A 
other than sinus, and no high grade obstructive CAD (-70% steno~,~) were 
(~xcluded from the study. Collateral flow was graded from 0 to 2 by two blinded 
mterventional cardiel0gisfs, 
Results: O135 l;~tients, 16 had heart r~les -~50 and the remaining 19 had 
ratea ~65, Both groups w~re pmdeminantly male with mean ~ge of 67 ~nd 
66, rasp~-'~'Ively, Lelt veeft'lo~!M ltm~on wa~ preserved with moan e(0¢l~on 
froctlof~ of 57% m both grou~. 94% of the btadYc~rdi~ p~tiertt~ de~eloped 
co!l~ter~ts with 69% ~nst rdt lng  grade ~ al~l 25% gr~ 1 Collaterals 
In the cqntffil group, 57% d~v~toged ¢;;~t!~ter~!s with 47% gra~ ~ and 10% 
grild~ 1 ~d!i~tori~!li, ~t~tistlcal ~l~llysis rwe~l!s lgr~ificaolly gaoler (.~oll~torats 
in br~dy~-~c p,~tienl~ o~111~ted 10 m~tel~l control~ (p .~ 0.0~5). 
C,m~s~1: Ttlis ~tt~J,/d(m~nstmtes A cef~'el~tton ~tween br~dy¢~rd*~ 
arid collateral ~S~I growth in p~t~nts with CAD, This finding has II~t#nfial 
clinical irnpl¢~fions in t!'~ m~an~g~ment of chren~(~ CAD, ttr~dVcardic a~nts 
n~y b~ U~tBl~l in p/orP,.olit,~g ~r@ogen~s~s, 
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A g, AnllM-Indtu~;ed OeaenslUzalion o! Human Cardiac 
/~=- drenoceptors: In Vivo Studies in IMsIthy 
VOlunteotS 
J Jakul~t~ U. Polar. J, Radke. K P0n~cke. O ,E  Broctde. In~bfu~e Ot 
PhamtacQ~, Unwemity at Haffe*Wiff~ntterg. Hal@. Germany 
Background: In the human heart a con~-~=~bte amount el tE,-adrenoceptors 
fAR) exist mediat~l inmeases in heart rate (HR) and ct~tractility (CON). We 
stud~ed whether chmn¢ agomsHreatmenl r,',=., desensitize card~ac tt~.AR. 
Methods: We assessed =n 16 mate healthy volunteers HR-increases and 
shortenmg el HR-corrected efeclromechanical systole (OS.~c as measure of 
=eetrop~sm) induced 'at the full- t~-AR agenrsts ted0~taline (I"ER acting at 
~-AR) and isopreea/me (ISO actmg at p'* and t~-AR) and the par~al ~AR 
agonist cehpralol (CEL acting at ~-AR) before and alter 14d TIER (3 ~ 5 
rag/flay p.o.)-treatmant. 
Resutts: Ek~tore TER-t~eatmera TER.mfusion (50--150 ng/kg/min) m- 
creased HR and shortened QS~ c mealy ~ia t~-AR stimulahon but a small 
tit -All component was also in¢ludecl, tSO-mfustOn (3.5-35 ng/kg/min)..ev0ked 
HR-lncraases in~olved #~- and t~-AR to the same extent while QS~c-sh~rten- 
mg was mediated meaty by tfl-AR stimulatmn CEL (600 mg p.o.) evoked HR- 
~ncfea~es and QS;c-shortening wa t~-AR stimulation but to a lesser extent 
than ISO or TER After TER-treatment TER- and ISO.intusion evoked HR- 
mereases and QS~e-sh~rtening was sige=ficantly attenuated whereby TER- 
effects were markedly more desensitized than IS@effects. CEL.mduced 
HR-increase and OS;.c-shertentng was abohshed; moreover CEL reduCed 
basal (alter TER-treatment elevated) HR and CON. 
Conclusron: 1) Human cardiac t~-AR are subtype-sele,3~,e;y desen,~t~zed 
following 14 d treatment w~th a/'~-AR agonist 2) lSO-evoked CON-~noreasP.S 
tnolud~ a t~-AR component and 3) the partial P-AR agomst eEL behaves in 
the presence ot an activated/'~-AR system like a ~-AR antagonist. 
~ Janus Kinase 2 Is Activated by Angioteosln II via G 
Proteins of the Gi Subfamily in Rat Neonatal 
Ca~liac MyoCytes 
J. Carlson t . J. Theilade ~ ,$, 1Bell z. S. Haunso ~ . S.P. Sheikh t z, ~Dept. of 
Medzcme B, National Unn,ersi~/ Hospital. Copenhagen. Denmark: "~Dept. 
Cell. & MoI. Pnann., University of California. San Francisco. CA 94143. USA 
Background Janus kinase 2 (Jak?-) is activated by cell surface receptors of 
the cytokine family and G protein-coupled receptors, and may be involved 
in confemng the hypedrophic properties ot these receptors. Wh~le Jak,?. 
activation is achieved by direct assooat~on with intracellular domains of the 
cytokine receptors, the mechanism of Jak2 activation by G pr0tein-coupled 
receptors is unknown. 
Methods: Pnmary cell cultures from neonatal rat hearts were stimulated 
with Angiotensin II fAng II) alter transtection with cD=,IA's coding tor G protem 
subunits and/or treatment with p~."tussis toxin. Jak2 and signal transducers 
and activators of transcription (STATs) activation were detected by i,mmuno- 
precipitation and western blotting. 
Results: Jak2 and STAT1 & 3 were activated by Ang II in rat cardiomy- 
oeytes in a time-dependent manner. Pertussis toxin blocked this activation, 
Transfection with/~-adrenergic receptor kinase minigen (flARK miniger,) also 
prevented Jak2 activation by Ang II. 
Conclusion: Our data demonstrate that G proteins of the G, subfamily 
play a role in Jak2/STAT activation by Ang I1. Interestingly, it is likely that 
beta:/,*subun~t hl)~r~t~on tS a rrecesS~n t step for JalVSTAT actwatton Thence 
results suggest hat tho G, faredy arKI #~. p ~ys ~ role n changmg tr~nscnp1!on 
following hormonal ~timulation of the I~earl 
• Differential Regulstton of ¢a~111¢ IIofomt= of 
l~'oteln Klnaae C In l=opmtemoH~u, md ¢a~1!i¢ 
HYl~l' lrophy 
MU, Bragn, K I~!irkp,~¢, B, Pauke, G, Simoni~, R,H Str~ssftr Un#~f~y ot 
HCK!ett~erg, H~t~er  9. Gem~lny 
Ba¢~eund; P-adrener(;~ receptor ~fim~l~ti0n W chm_~ mf~,~,on Ot SOpm, 
t~fer~l (1~0) re~lt~ in c~r~i~¢ hyperlr01~y, It Ihi~ chf0niC ~timulal~l~n el cAMP 
dep~edent ~gnal!ing I'J~thwi~y ff'~y mo(~late lh~ aclMly ~t,~ expre~s,~ Ot 
cenfr4f o ~  tn grow~ft a~ d~ffe,entiafK~. I 0lein kinsse C. h~s net 
cbar~;~lenzed, 
Method: To a~reS~ thi~ questi0n, ISo w~s ~ut~utan~ush/a¢lmm~lered 
to r~l~ by osmotic minil~ump~ (:~ mg Iso/kg ,, d), Afte~ ? days caKfiac PKC~ 
a¢l~vffy and the e~q~ms~on f PKG.isoform~ both at tile protem level using 
Western blot analysis with subtypo~spe~dm ~ntll:~O~leS and the mRNA-lavel 
u~ing RT-PCR w~r~ ~termir,~, 
Result.~; Card~a¢ hypedrephy was shown by the increased heaff-tO.boUy 
we~tht ratio in Iso-treatea rats (2.7 g/kg ~ 02. vs 3.4 gJkg ~ 0~.; p ~ 0.05, 
n = ~). The speQf¢ PKC-actMty in the Cytosol it, re'eased up t n t30% (2B9 
5,9 vs 221 ~+ 43 pmollmg protein . rain). E~q~rass~on OfPKC,-~ and PKC-,~ 
increased in hypertrophic hearts significantly, whereas the isotorms PKC-~, 
and PKC~zeta; remained unaltered. Furthermore, in Iso-treated mrs (n : 8), 
the mRNA-level I~lh o! P~C,-,~ (97'8 _ 128 va 486 _+ 56 agmg totaI-RNA, p 
005} andof PKC~ (f654 ~ 144vag88 :~ 112 ag/ng fotaI.,RNA, p ~ 0,05) 
were slgnifcantly increased. In ¢onlr~st, he steady-slale mRNA levels tot 
PKC,~ were unchanged (246 ± 36 vs 2q9 ~ 40 ag/ng tataI-RNA). 
C.Onclus~on~: l"he..7~e data show that cardiac hypedrophy induced by 
chronic tl-adrene~gK: stimulatlo~ promotes an inoreased actn~/of pmlem 
kma~se C wrth e newly ellaracter~ed, sUbtype-seleclive expressional regula~ 
t~on ot the novel PKC-P~otorms PKC~ and PKC-, 
[1038-9 1 A Recombinant. CMV Promoter-driven G 
Protein-coupled Receptor in Cardiomyocytes Is Not 
Downregulated bv Agonists 
M Ungerer, K.-L. Laugwttz, H.-J. Weig, K, Kronsbeln, K. Hoffmatln, 
A Schomtg C/eursche,s Hetz, z'entrum anti 1. ~ ,~nE,  ct',e Klimk, 
Technische Un~'ersrtaf Munich, Germany 
Obiect/ve: We c~mpared the homologous desensitization and downmgula- 
t~on el endogenous t{-raceptors (pAR) with Ihat OTa recombinant, hetemlo- 
gous G'~-coupling receptor in cardL~my~ytes 
Methods: We used a recombinant adenev]rus for the human V2 va. 
sepressm .eceptor under the express~on control of a CMV promoter (Ad~ 
CMV-V2R). Ad-CMV-V2R-mfected cardmmyocytes were subiecled to age, 
nist ~mulatmn of natwe pAR and of mc~nbnant V2 vaSopressin receptorS 
(rV2R). For this pu~ose, the cells were exposed to either isopmtemnol (iso) 
for natrve pAR or argtnme vasowessm (AVP) for rV2R for different periods of 
time, Agenist exposure led to a ral~d desensitization ot endogenous t~AR on 
the short run. and to further eduction el cAMP accumulation after longer incu- 
bation peneds wh~'h was due to pAR dewnregutafion. Incontrast, rV2R were 
desensitized tnitia~y, but ware not subject o doworeguletton, rV2R density 
did not change significantly after 20 hourS of agorsst exposure (Table). 
Agomsi exposure: 0 rain 15 mm 20 h 
ReCeptor ~nsl~,, ffmol~mg protemJ 
pAR. TSO pre-expmJure 60 • 5 55 • 6 25 ± 6" 
rV~R. AVP pre-oxl~oCjure 789 ~ ;tOO 723 : 160 741 .: 168 
AgomsNnduced cAMP accumulation ftoM over ba,£,~tll 
riAR, ~ gre~,xpo~ure 42 = 09 t 7 ~" 05' 1 1 : 02'" 
rV;~R. AVP pro-exposure 7 : t 6 5 1 *.: 0 2" 52 ~ 1 1' 
(n ~ 3-5. 'p • 6 05 "'p - 0 01 v$ 0 mmuto.~ 
Conclusion: Heterologous recombinant rV;tR are desensitized but not 
downregulated incardiomyocytes. Therefore. we presume that rV2R am not 
SUDleCt to endogenous regulation el expmss~on, but only to protein modifi- 
cation Consequently, rV2R might be used for bypassing t~AR to stimulate 
cAMP over longer time peneds 
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